Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections, and C. 19 pneumoniae causes community-acquired respiratory infections. In vivo, the host immune system 20 will release interferon-gamma (IFNγ) to combat infection. IFNγ activates human cells to produce 21 the tryptophan (trp) catabolizing enzyme, IDO. Consequently, there is a reduction in cytosolic trp 22 in IFNγ-activated host cells. In evolving to obligate intracellular dependence, Chlamydia has 23 significantly reduced its genome size and content as it relies on the host cell for various nutrients. 24 Importantly, C. trachomatis and C. pneumoniae are trp auxotrophs and are starved for this essential 25 nutrient when the human host cell is exposed to IFNγ. To survive this, chlamydiae enter an 26 alternative growth state referred to as persistence. Chlamydial persistence is characterized by a 27 halt in the division cycle, aberrant morphology, and, in the case of IFNγ-induced persistence, trp 28 codon-dependent changes in transcription. We hypothesize that these changes in transcription are 29 dependent on the particular amino acid starvation state. To investigate the chlamydial response 30 mechanisms acting when other amino acids become limiting, we tested the efficacy of prokaryotic 31 specific tRNA synthetase inhibitors, indolmycin and AN3365, to mimic starvation of trp and 32 leucine, respectively. We show that these drugs block chlamydial growth and induce changes in 33 morphology and transcription consistent with persistence. Importantly, growth inhibition was 34 reversed when the compounds were removed from the medium. With these data, we find that 35 indolmycin and AN3365 are valid tools that can be used to mimic the persistent state independently 36 of IFNγ. 37 Word Count: 248/250 38 39 3 Importance 40
To help distinguish between the possible reasons for a loss in recoverable IFUs, 152 immunofluorescence microscopy was used to analyze chlamydial morphology (Fig. 3 ). HEp-2 153 cells were infected with C. trachomatis serovar L2, treated or not with the indicated compounds 154 at 10 hpi or pre-treated with IFNγ as described in Materials and Methods, and fixed and processed 155 for imaging at 24 hpi. Both indolmycin and AN3365 treatment resulted in noticeably larger 156 individual organisms, similar to that observed during IFNγ treatment (16) . Electron microscopic 157 analysis of organisms treated with inhibitors also revealed aberrant morphology (Suppl. Fig. 1 ). 158 Interestingly, the labeling of MOMP was not uniform around the membrane of the organisms in 159 the treated cells. The ompA gene encodes 30 leu (L) and 7 trp (W) codons. Decreased availability 160 of L or W may therefore negatively impact translation of MOMP that in turn may lead to non-161 uniform localization along the organism's membrane (see also (16) ). Conversely, Hsp60_1, which 162 contains 0 W codons, appeared abundant in both indolmycin and IFNγ-treated samples. 163 Interestingly, Hsp60_1 is also abundant in the AN3365 treated sample despite the presence of 45 164 L codons. These observations are consistent with what has been previously described during IFNγ-165 induced persistence (12) . Taken together, these morphological data in conjunction with the IFU 166 data presented above support the conclusion that the organisms are non-replicative, display an 167 aberrant morphology, and are not proceeding through the normal developmental cycle.
169
Removal of indolmycin and AN3365 rescues C. trachomatis growth and morphology. 170 A key characteristic of persistence is its reversibility such that the organism can revert back 171 to a developmentally competent RB. To determine whether or not C. trachomatis remains viable 172 under indolmycin or AN3365 treatment, we attempted to rescue the organisms by removing each with the designated compounds at 10 hpi. Treatment media was aspirated at 24 hpi, and samples 175 were washed 3x with DPBS before replenishing with DMEM. After 24 and 48 hour recovery 176 periods following drug removal, IFUs were quantified and organism morphology was assessed. In 177 the presence of indolmycin and AN3365, chlamydial growth was inhibited up to 72 hpi ( Figure   178 4A). After removal of these compounds from the medium, chlamydial growth was restored as 179 represented by a logarithmic increase in IFUs at 48 (24h post recovery) and 72 (48h post recovery) 180 hpi. These IFU data were corroborated by the detection of normal morphological forms at these 181 time points that were indistinguishable from 24 and 48 hpi untreated organisms Indolmycin and AN3365 induce morphological aberrance in C. pneumoniae. 191 Although the underlying mechanisms of persistence are unknown, we hypothesize that they 192 are conserved between C. trachomatis and C. pneumoniae. C. pneumoniae is a slower growing 193 species compared to C. trachomatis, particularly the L2 serovar, suggesting it would be equally, if 194 not more, sensitive to tRNA synthetase inhibitors. Therefore, we suspected the use of indolmycin 195 and AN3365 on C. pneumoniae would produce a phenotype similar to that observed during IFNγ 196 exposure. To test this, we infected HEp-2 cells with C. pneumoniae AR39. Samples were treated or not with the designated compound at 24 hpi or with IFNγ at time of infection. As seen in Figure   198 5, the morphologies of organisms treated with indolmycin or AN3365 closely resemble those 199 treated with IFNγ. We conclude from these data that tRNA synthetase inhibitors are broadly 200 applicable to study persistence in Chlamydia species.
202
The bacterial tRNA synthetase inhibitors induce transcriptional changes consistent with 203 IFNγ-mediated persistence. 204 To determine whether the tRNA synthetase inhibitors induce transcriptional changes 205 consistent with persistence, nucleic acids were isolated from infected cultures, and the abundance 206 of selected transcripts was measured and normalized to genomic DNA content. Increased 207 transcription of euo has been previously associated with IFNγ-mediated persistence (18, 30) . This 208 elevated transcriptional response was observed in both C. trachomatis (beginning at 4h post 209 treatment) and C. pneumoniae when exposed to either indolmycin or AN3365 treatments and 210 resembled IFNγ-induced persistence (Fig. 6A ). In addition to euo, groEL_1 has also been 211 implicated in persistence and general stress response (30). We analyzed the abundance of groEL_1 212 transcripts in both C. trachomatis and C. pneumoniae under each treatment ( Fig. 6B ). In agreement 213 with previous findings, groEL_1 transcripts remained unchanged (<1.5x difference) in C. pneumoniae, all treatment conditions followed a similar transcript pattern as in untreated samples 219 for groEL_1. This is also consistent with previous observations for IFNγ-induced persistence in this organism (18). Additionally, indolmycin treatment resulted in a rapid (4h) and large increase 221 in trpB transcripts (C. pneumoniae does not encode trpB), a gene that is repressed under trp-replete 222 conditions ( Fig. 6C and (31) ). This suggests C. trachomatis has detected and is quickly responding 223 to a lack of trp. Moreover, there is a noticeable increase in trpB transcripts at 24 hpi following 224 AN3365 treatment (3-4 fold increase). Considering the lack of change observed at 14 hpi, the 225 increase of trpB transcripts at 24 hpi may be an indirect effect caused by a cascade of responses 226 rather than an immediate reaction to leu limitation. It is important to note that while C. trachomatis 
234
To determine whether indolmycin and AN3365 could mimic a more nuanced characteristic of 235 IFNγ-induced persistence, we looked to the ytgABCD operon (26). As previously described by ratio is approximately 5-10 but increases to over 30-fold or higher during IFNγ-mediated trp 239 starvation. We hypothesized that this skew was caused by ribosome stalling along the transcript 240 due to the lack of charged tRNAs, which allows Rho to bind internal rut sites to terminate 241 transcription prematurely (32). Of note, within the ytgC gene is the presence of three tandem W with 98 total residues in ytgB and ytgC and a total of 11 LL motifs in C. trachomatis. We reasoned 244 that both indolmycin and AN3365 should produce the same phenotype as a result of the stalling 245 of ribosomes on trp codons, in the case of indolmycin treatment, or leu codons, in the case of 246 AN3365 treatment, respectively. We quantified ytgA and ytgD transcripts at different times after 247 addition of the tRNA synthetase inhibitors (at 10hpi for Ctr, 24hpi for Cpn) and compared the 248 ratios to those from IFNγ-treated cultures. As anticipated, both indolmycin and AN3365 treated 249 samples resembled the IFNγ-induced persistent state with regards to the polarity of the ytg operon, 250 shown in Figure 7 as a disproportionate level of ytgA to ytgD transcripts. Interestingly, differences 251 in the Ctr ytgA:ytgD ratio were observed within four hours of treatment (14hpi) and were more 252 pronounced for L limitation (AN3365) than for W limitation (indolmycin or IFNγ) ( Fig. 6A ). This 253 is consistent with the larger number of L versus W residues in the operon. However, by 24hpi, the 254 ytgA:ytgD ratio for all treatments was similar, possibly reflecting a recovery in read-through 255 potential in AN3365-treated cultures. For Cpn, all treatments resulted in the expected increase in 256 ytgA transcripts in proportion to ytgD transcripts when measured at 48hpi (after treatment at 257 24hpi). Overall, these data demonstrate that the tRNA synthetase inhibitors recapitulate key 258 characteristics of amino acid starvation in Chlamydia.
Discussion

261
Persistence is an important but poorly understood aspect of chlamydial diseases. The 262 immunological basis for inducing persistence in cell culture was first described by Beatty et al. in 263 1993, who described the effects of IFNγ, and its reversibility, on chlamydial growth and 264 morphology in human cell lines (12, 16, 25) . These effects were connected with the ability of 265 human IFNγ to induce a tryptophan-limiting environment in the cell by activating IDO expression 266 (12). Broadly speaking, these effects are likely mediated by the inability to efficiently translate 267 key proteins enriched in trp residues (see Fig.1 and (18, 33, 34) ). More recent studies have 268 characterized transcriptional and translational changes associated with IFNγ-mediated persistence 269 (18, 30). More importantly, these "persistence" characteristics as defined in cell culture models to EBs and EBs are rapidly accumulating (e.g. Fig. 2A ). For IFNγ to be effective, pretreatment of 281 host cells with IFNγ prior to infection is required, yet this strategy is inconsistent. To induce a 282 persistent state in serovar L2, we recently published a protocol that described the pretreatment of cells with IFNγ prior to infection followed by the addition of IFNγ-conditioned medium at 10 hpi 284 (32). This allows IDO to be sufficiently expressed and trp to be catabolized, resulting in small Here, we sought to evaluate the effects of characterized bacterial tRNA synthetase 295 inhibitors (28, 29, 42) for their ability to induce persistence in Chlamydia as a first step in 296 developing systems that would allow us to mechanistically address this alternative growth state.
297
Such an approach would offer immediate advantages over IFNγ-mediated tryptophan limitation in 298 that a translation block (i.e. starvation mimicking condition) could be induced immediately upon 299 addition of the inhibitors. By using E. coli tRNA turnover rates as a guide, we hypothesize that the 300 pool of charged trp-tRNA or leu-tRNA would be depleted within seconds after treatment (43).
301
This would allow more direct comparisons between research groups with less variability in 302 experimental systems. In particular, the use of inhibitors circumvents the host cell's ability to 303 regenerate amino acid pools through autophagy, which would occur in conditions where an amino 304 acid is omitted from culture medium. Indeed, we observed that, under such conditions, although 305 the absence of trp was sensed, as demonstrated by increased trpB transcripts, euo transcripts, a marker of persistence, did not increase (Suppl. Fig. 2 ). This suggests that, for serovar L2, simply 307 omitting amino acids from the culture medium is not sufficient to induce a bona fide persistence 308 response.
309
These data indicate the ability of indolmycin and AN3365 to induce persistence by limiting 310 Chlamydia's use of a single specific amino acid by blocking the charging of its cognate tRNA.
311
Considering the parallels in morphology, transcriptional response, and mode of stress caused by 312 these compounds in comparison to IFNγ, we conclude that the use of indolmycin and AN3365 in 313 place of IFNγ is a viable method to study amino acid starvation stress responses. Interestingly, 314 indolmycin treatment replicates the key transcriptional and morphological phenotypes associated 315 with IFNγ-induced persistence, further supporting that tryptophan limitation is the main 316 antichlamydial inhibitory mechanism of IFNγ in human cells (11, 19) . The transcriptional changes 317 of C. pneumoniae in response to the inhibitors more closely mirrored IFNγ-mediated persistence 318 than C. trachomatis did. Given the slower growth rate of C. pneumoniae, this is not surprising.
319
The greater heterogeneity in transcription responses between indolmycin and IFNγ in C. 320 trachomatis may be due to the organism's quicker developmental cycle and asynchronous nature.
321
That being said, the difference between the tryptophan starvation condition in C. pneumoniae 322 versus C. trachomatis was not more than four-fold and showed the same trends overall.
323
AN3365-induced leu starvation displayed noteworthy differences from the trp starvation 324 conditions. Firstly, groEL_1 transcripts generally increased during the analysis in C. trachomatis. 325 This is consistent with what we previously characterized as codon-dependent transcriptional 326 changes during amino acid starvation as Hsp60_1 contains 45 L residues (26). Secondly, trpB 327 transcripts were not increased 4h after treatment, as expected since leu starvation should not 328 activate expression of the trpRBA operon. However, 14h post treatment, there was an approximately 3-fold increase in trpB levels, suggesting some de-repression of the operon. TrpR 330 contains 11 leu residues including one LL motif. Therefore, the inability to efficiently translate the 331 repressor over time may allow for gradual transcriptional activation of the operon. Alternatively, 332 the recently described role for the iron-sensitive repressor, YtgR, in blocking transcription of 333 trpBA, may also be important (44). The YtgCR protein contains approximately 60 leu residues 334 with multiple LL motifs that likely prevent efficient translation of this sequence. This is under 335 investigation, but we also observed transcriptional changes in the ytg operon (see below). 336 We recently demonstrated differences in transcript levels between the 5' and 3' ends of 337 large monocistronic and polycistronic transcripts (26). We further connected this to Rho-338 dependent polarity prematurely terminating transcription in trp-codon rich transcripts during IFNγ-339 mediated trp starvation (32). To determine whether the tRNA synthetase inhibitors could replicate 340 the destabilization of the 3' end of a large transcript, we analyzed the abundance of the ytgA and 341 ytgD transcripts. Consistent with what was previously observed for IFNγ-mediated trp starvation, 342 both indolmycin and AN3365 caused a disparity in transcript abundance between the 5' and 3' 343 ends of the ytg operon. Interestingly, AN3365 caused a quick destabilization of ytgD transcripts in 344 C. trachomatis before recovering to levels observed in trp starvation conditions. The reasons for 345 this are not clear but are under investigation.
346
The tools described here to mimic specific amino acid starvation states, by blocking tRNA 347 charging, in the absence of chemokines or other significant alterations to culture conditions will 348 facilitate broad comparisons of chlamydial persistence between species. For example, C. caviae 349 resists IFNγ-mediated persistence by recycling the product of trp degradation, N-350 formylkynurenine, through a trp scavenging pathway (45). Indolmycin treatment will facilitate 351 studies of trp starvation responses in this species. Likewise, these treatments can be used in mouse cells, where IDO is not the primary antichlamydial effector (10, 46) . Also of interest are other 353 intracellular pathogens such as Coxiella or Rickettsia, as studying their response mechanisms to 354 amino acid starvation could lead to a greater understanding of evolutionary strategies employed 355 by obligate intracellular pathogens, which typically lack functional stringent responses, to adapt 356 to this stress.
357
Following the validation of these compounds as tools to study persistence, we aim to 358 further investigate the role of amino acid limitation in regulating the persistent state. With the 359 ability to limit an amino acid other than trp, we can more rigorously test the hypothesis that trp 360 limitation increases transcription of trp codon containing genes to determine if this is a broad 361 response to amino acid limitation or perhaps something specific to trp (26). We can now also apply 362 genetic tools to study amino acid starvation responses in C. trachomatis L2.
Organisms and cell culture. The human epithelial cell line HEp-2 was routinely cultivated at
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Representative images of HEp-2 cells infected with C. trachomatis and treated or not as indicated.
619
Cells were fixed and stained 24 hpi using primary antibodies to Major Outer Membrane Protein Supplemental Table 1 . All primer sequences used for qPCR analysis of a given transcript. Figure 6 . Transcriptional changes in Chlamydia consistent with persistence can be detected during indolmycin and AN3365 treatment. A) Transcripts of euo are elevated in C. trachomatis (Ctr) or C. pneumoniae (Cpn) following treatments with indolmycin, AN3365, or IFNγ. B) Under standard conditions, groEL_1 transcripts in C. trachomatis decrease between 10 and 24 hpi. However, treatment with indolmycin results in unchanged transcript levels, similar to what is seen in IFNγ treated samples, while AN3365 treatment results in higher transcript levels. In C. pneumoniae, no significant change is seen between 24 and 48 hours under any treatment, in agreement with previous reports investigating IFNγ exposure. C) trpB transcripts accumulate at 14 hpi as expected in indolmycin and IFNγ treated samples, but not in AN3365. At 24 hpi, AN3365 treated samples exhibit a slight (3-4 fold) increase in trpB. Each was normalized to gDNA collected from replicate wells and expressed as a ratio of ng cDNA per ng gDNA of ytgA over ytgD.
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